Phase I studies have become increasingly complex; and sponsors, now more than ever, rely on data from these studies to make important decisions about their development programs. Therefore, sponsors must rely on vendors that provide a high standard of service.
Clinilabs’ 68-bed, state-of-the-art Phase I facility provides standard pharmacokinetic (PK), pharmacodynamic (PD), bioavailability (BA), bioequivalence (BE), and interaction studies. The Company also offers specialty services for complex PD studies, such as those that involve the collection of mood, cognition, psychomotor functioning, EEG, quantitative EEG, evoked potential (EP), and imaging data. Our Phase I facility is staffed by a group of experienced physicians, nurses, and research associates who provide coverage 24 hours a day, 7 days a week.
Populations represented in Clinilabs’ large subject database include, but are not limited to, healthy adult, healthy elderly, Japanese, Chinese, renal-impaired, and hepatic-impaired people, as well as individuals with histories of alcohol and substance abuse.
|
